Back to Authors

Tai, Felicia

https://orcid.org/0000-0003-0652-6946

Mayo Clinic

University of Toronto

Citations 2

Laser Resurfacing Monotherapy for the Treatment of Actinic Keratosis
Tai, Felicia , Shah, Monica , Pon, Kucy, Alavi, Afsáneh , Alavi, A , Shah, Monica

Journal of Cutaneous Medicine and Surgery | July 2, 2021 | Volume: 25 | Issue: 6 | Pages: 634-642

10.1177/12034754211027515 Get It

Treating actinic keratosis (AK) and photodamaged skin is critical to reduce the risk of progression to skin cancer. Laser resurfacing for AK treatment is available as either lesion-directed or field therapy. Laser resurfacing removes the superficial epidermis and dermis containing actinic damage, promoting re-epithelialization of healthy skin. Although laser resurfacing has been explored as a modality for AK treatment in the literature, studies summarizing its efficacy in the treatment of AK are lacking. This review summarizes existing research on laser resurfacing as a monotherapy for AK treatment, highlighting the various laser resurfacing modalities available for AK treatment as well as their complications and efficacy in comparison to other therapies. Despite longer healing time, fully ablative laser resurfacing, including carbon dioxide and erbium-doped yttrium aluminum garnet were found to be more effective for AK treatment than fractional ablative techniques. Although some studies suggest laser resurfacing monotherapy as less efficacious than photodynamic therapy, and equally effective to 5-fluorouracil and 30% trichloroacetic acid, clinical trials of larger sample size are required to establish stronger evidence-based conclusions. Moreover, laser resurfacing used as lesion-directed therapy, as opposed to the usual field-therapy, requires further investigation.
Measuring fatigue: a meta‐review
Machado, Myrela O. , Kang, Na‐Young Cindy , Sambhi, Raman D. S., Berk, Michael , Carvalho, André F. , Pérez-Chada, Lourdes M. , Piguet, Vincent , Chada, Lourdes P , Piguet, V , Berk, Michael , Tai, Felicia , Sambhi, Raman-Deep Singh, Merola, Joseph F. , Alavi, Afsáneh

International Journal of Dermatology | December 11, 2020 | Volume: 60 | Issue: 9 | Pages: 1053-1069

10.1111/ijd.15341 Get It

AbstractThere is a lack of validated tools to measure fatigue in patients with inflammatory skin, neuropsychiatric, and medical disorders. The use of nonvalidated tools may compromise the quality of data. The purpose of this meta‐review was to evaluate existing fatigue scales commonly used to assess fatigue in other inflammatory conditions and to identify if there are scales that have been validated in dermatologic conditions. The PubMed/MEDLINE and SCOPUS databases were systematically searched from inception through March 10, 2020, in accordance with the PRISMA statement. Validated tools were identified and assessed according to their main measurement properties. The literature search identified 403 references, and eight studies were eligible and assessed in this review. The unidimensional fatigue scales included were the Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT‐F), Brief Fatigue Inventory, Fatigue Severity Scale, Numerical Rating Scale – Fatigue, and Visual Analog Scale – Fatigue. The multidimensional fatigue scales found were the Checklist Individual Strength, Chalder Fatigue Scale, Multidimensional Assessment of Fatigue, Multidimensional Fatigue Inventory Scale, and Piper Fatigue Scale. To measure fatigue, a brief scale with the ability to detect change is needed as there is a growing interest in evaluating this dimension of treatment response. In addition, a good content validity is also needed. From this systematic review, none of the selected scales have had content validation, even though the FACIT was validated in patients with psoriatic arthritis. Validation studies in specific disorders are urgently warranted.